line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-127919703.363579,MEDANTA.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.256373,MEDANTA.NS
Normalized EBITDA,2025-03-31 00:00:00,9561600000.0,MEDANTA.NS
Total Unusual Items,2025-03-31 00:00:00,-498960000.0,MEDANTA.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-498960000.0,MEDANTA.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,4814370000.0,MEDANTA.NS
Reconciled Depreciation,2025-03-31 00:00:00,1937480000.0,MEDANTA.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,8796690000.0,MEDANTA.NS
EBITDA,2025-03-31 00:00:00,9062640000.0,MEDANTA.NS
EBIT,2025-03-31 00:00:00,7125160000.0,MEDANTA.NS
Net Interest Income,2025-03-31 00:00:00,-652590000.0,MEDANTA.NS
Interest Expense,2025-03-31 00:00:00,652590000.0,MEDANTA.NS
Interest Income,2025-03-31 00:00:00,,MEDANTA.NS
Normalized Income,2025-03-31 00:00:00,5185410296.636421,MEDANTA.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,4814370000.0,MEDANTA.NS
Total Expenses,2025-03-31 00:00:00,30090000000.0,MEDANTA.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,MEDANTA.NS
Diluted Average Shares,2025-03-31 00:00:00,,MEDANTA.NS
Basic Average Shares,2025-03-31 00:00:00,,MEDANTA.NS
Diluted EPS,2025-03-31 00:00:00,,MEDANTA.NS
Basic EPS,2025-03-31 00:00:00,,MEDANTA.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,4814370000.0,MEDANTA.NS
Net Income Common Stockholders,2025-03-31 00:00:00,4814370000.0,MEDANTA.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,MEDANTA.NS
Net Income,2025-03-31 00:00:00,4814370000.0,MEDANTA.NS
Minority Interests,2025-03-31 00:00:00,1190000.0,MEDANTA.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,4813180000.0,MEDANTA.NS
Net Income Continuous Operations,2025-03-31 00:00:00,4813180000.0,MEDANTA.NS
Tax Provision,2025-03-31 00:00:00,1659390000.0,MEDANTA.NS
Pretax Income,2025-03-31 00:00:00,6472570000.0,MEDANTA.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,790970000.0,MEDANTA.NS
Special Income Charges,2025-03-31 00:00:00,-498960000.0,MEDANTA.NS
Other Special Charges,2025-03-31 00:00:00,,MEDANTA.NS
Write Off,2025-03-31 00:00:00,,MEDANTA.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-652590000.0,MEDANTA.NS
Total Other Finance Cost,2025-03-31 00:00:00,,MEDANTA.NS
Interest Expense Non Operating,2025-03-31 00:00:00,652590000.0,MEDANTA.NS
Interest Income Non Operating,2025-03-31 00:00:00,,MEDANTA.NS
Operating Income,2025-03-31 00:00:00,6833150000.0,MEDANTA.NS
Operating Expense,2025-03-31 00:00:00,21293310000.0,MEDANTA.NS
Other Operating Expenses,2025-03-31 00:00:00,6136980000.0,MEDANTA.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,1937480000.0,MEDANTA.NS
Amortization,2025-03-31 00:00:00,,MEDANTA.NS
Depreciation Income Statement,2025-03-31 00:00:00,1937480000.0,MEDANTA.NS
Research And Development,2025-03-31 00:00:00,,MEDANTA.NS
Selling General And Administration,2025-03-31 00:00:00,4973430000.0,MEDANTA.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,MEDANTA.NS
General And Administrative Expense,2025-03-31 00:00:00,4973430000.0,MEDANTA.NS
Rent And Landing Fees,2025-03-31 00:00:00,,MEDANTA.NS
Gross Profit,2025-03-31 00:00:00,28126460000.0,MEDANTA.NS
Cost Of Revenue,2025-03-31 00:00:00,8796690000.0,MEDANTA.NS
Total Revenue,2025-03-31 00:00:00,36923150000.0,MEDANTA.NS
Operating Revenue,2025-03-31 00:00:00,36923150000.0,MEDANTA.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,MEDANTA.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.237664,MEDANTA.NS
Normalized EBITDA,2024-03-31 00:00:00,8737400000.0,MEDANTA.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,MEDANTA.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,MEDANTA.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Reconciled Depreciation,2024-03-31 00:00:00,1727280000.0,MEDANTA.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,7593600000.0,MEDANTA.NS
EBITDA,2024-03-31 00:00:00,8737400000.0,MEDANTA.NS
EBIT,2024-03-31 00:00:00,7010120000.0,MEDANTA.NS
Net Interest Income,2024-03-31 00:00:00,-739130000.0,MEDANTA.NS
Interest Expense,2024-03-31 00:00:00,739130000.0,MEDANTA.NS
Interest Income,2024-03-31 00:00:00,596780000.0,MEDANTA.NS
Normalized Income,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Total Expenses,2024-03-31 00:00:00,26487630000.0,MEDANTA.NS
Rent Expense Supplemental,2024-03-31 00:00:00,621050000.0,MEDANTA.NS
Diluted Average Shares,2024-03-31 00:00:00,268648315.0,MEDANTA.NS
Basic Average Shares,2024-03-31 00:00:00,268648315.0,MEDANTA.NS
Diluted EPS,2024-03-31 00:00:00,17.8,MEDANTA.NS
Basic EPS,2024-03-31 00:00:00,17.8,MEDANTA.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Net Income Common Stockholders,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,MEDANTA.NS
Net Income,2024-03-31 00:00:00,4781940000.0,MEDANTA.NS
Minority Interests,2024-03-31 00:00:00,1340000.0,MEDANTA.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,4780600000.0,MEDANTA.NS
Net Income Continuous Operations,2024-03-31 00:00:00,4780600000.0,MEDANTA.NS
Tax Provision,2024-03-31 00:00:00,1490390000.0,MEDANTA.NS
Pretax Income,2024-03-31 00:00:00,6270990000.0,MEDANTA.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,746640000.0,MEDANTA.NS
Special Income Charges,2024-03-31 00:00:00,0.0,MEDANTA.NS
Other Special Charges,2024-03-31 00:00:00,-8200000.0,MEDANTA.NS
Write Off,2024-03-31 00:00:00,293130000.0,MEDANTA.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-739130000.0,MEDANTA.NS
Total Other Finance Cost,2024-03-31 00:00:00,112420000.0,MEDANTA.NS
Interest Expense Non Operating,2024-03-31 00:00:00,739130000.0,MEDANTA.NS
Interest Income Non Operating,2024-03-31 00:00:00,596780000.0,MEDANTA.NS
Operating Income,2024-03-31 00:00:00,6263480000.0,MEDANTA.NS
Operating Expense,2024-03-31 00:00:00,18894030000.0,MEDANTA.NS
Other Operating Expenses,2024-03-31 00:00:00,5547890000.0,MEDANTA.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,1727280000.0,MEDANTA.NS
Amortization,2024-03-31 00:00:00,25020000.0,MEDANTA.NS
Depreciation Income Statement,2024-03-31 00:00:00,1727280000.0,MEDANTA.NS
Research And Development,2024-03-31 00:00:00,420000.0,MEDANTA.NS
Selling General And Administration,2024-03-31 00:00:00,4270280000.0,MEDANTA.NS
Selling And Marketing Expense,2024-03-31 00:00:00,291850000.0,MEDANTA.NS
General And Administrative Expense,2024-03-31 00:00:00,4270280000.0,MEDANTA.NS
Rent And Landing Fees,2024-03-31 00:00:00,621050000.0,MEDANTA.NS
Gross Profit,2024-03-31 00:00:00,25157510000.0,MEDANTA.NS
Cost Of Revenue,2024-03-31 00:00:00,7593600000.0,MEDANTA.NS
Total Revenue,2024-03-31 00:00:00,32751110000.0,MEDANTA.NS
Operating Revenue,2024-03-31 00:00:00,32751110000.0,MEDANTA.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-22750527.632487,MEDANTA.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.274235,MEDANTA.NS
Normalized EBITDA,2023-03-31 00:00:00,6849650000.0,MEDANTA.NS
Total Unusual Items,2023-03-31 00:00:00,-82960000.0,MEDANTA.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-82960000.0,MEDANTA.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Reconciled Depreciation,2023-03-31 00:00:00,1499150000.0,MEDANTA.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,6252850000.0,MEDANTA.NS
EBITDA,2023-03-31 00:00:00,6766690000.0,MEDANTA.NS
EBIT,2023-03-31 00:00:00,5267540000.0,MEDANTA.NS
Net Interest Income,2023-03-31 00:00:00,-507930000.0,MEDANTA.NS
Interest Expense,2023-03-31 00:00:00,774640000.0,MEDANTA.NS
Interest Income,2023-03-31 00:00:00,355360000.0,MEDANTA.NS
Normalized Income,2023-03-31 00:00:00,3320999472.367513,MEDANTA.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Total Expenses,2023-03-31 00:00:00,21837410000.0,MEDANTA.NS
Rent Expense Supplemental,2023-03-31 00:00:00,633670000.0,MEDANTA.NS
Diluted Average Shares,2023-03-31 00:00:00,259460833.0,MEDANTA.NS
Basic Average Shares,2023-03-31 00:00:00,259208847.0,MEDANTA.NS
Diluted EPS,2023-03-31 00:00:00,12.57,MEDANTA.NS
Basic EPS,2023-03-31 00:00:00,12.58,MEDANTA.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Net Income Common Stockholders,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,MEDANTA.NS
Net Income,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Minority Interests,2023-03-31 00:00:00,0.0,MEDANTA.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Net Income Continuous Operations,2023-03-31 00:00:00,3260790000.0,MEDANTA.NS
Tax Provision,2023-03-31 00:00:00,1232110000.0,MEDANTA.NS
Pretax Income,2023-03-31 00:00:00,4492900000.0,MEDANTA.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,137520000.0,MEDANTA.NS
Special Income Charges,2023-03-31 00:00:00,-82960000.0,MEDANTA.NS
Other Special Charges,2023-03-31 00:00:00,6770000.0,MEDANTA.NS
Write Off,2023-03-31 00:00:00,76190000.0,MEDANTA.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-507930000.0,MEDANTA.NS
Total Other Finance Cost,2023-03-31 00:00:00,88650000.0,MEDANTA.NS
Interest Expense Non Operating,2023-03-31 00:00:00,774640000.0,MEDANTA.NS
Interest Income Non Operating,2023-03-31 00:00:00,355360000.0,MEDANTA.NS
Operating Income,2023-03-31 00:00:00,4990630000.0,MEDANTA.NS
Operating Expense,2023-03-31 00:00:00,15584560000.0,MEDANTA.NS
Other Operating Expenses,2023-03-31 00:00:00,3132730000.0,MEDANTA.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,1499150000.0,MEDANTA.NS
Amortization,2023-03-31 00:00:00,25040000.0,MEDANTA.NS
Depreciation Income Statement,2023-03-31 00:00:00,1474110000.0,MEDANTA.NS
Research And Development,2023-03-31 00:00:00,340000.0,MEDANTA.NS
Selling General And Administration,2023-03-31 00:00:00,4211290000.0,MEDANTA.NS
Selling And Marketing Expense,2023-03-31 00:00:00,249070000.0,MEDANTA.NS
General And Administrative Expense,2023-03-31 00:00:00,3962220000.0,MEDANTA.NS
Rent And Landing Fees,2023-03-31 00:00:00,633670000.0,MEDANTA.NS
Gross Profit,2023-03-31 00:00:00,20575190000.0,MEDANTA.NS
Cost Of Revenue,2023-03-31 00:00:00,6252850000.0,MEDANTA.NS
Total Revenue,2023-03-31 00:00:00,26828040000.0,MEDANTA.NS
Operating Revenue,2023-03-31 00:00:00,26828040000.0,MEDANTA.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-10030236.95925,MEDANTA.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.300685,MEDANTA.NS
Normalized EBITDA,2022-03-31 00:00:00,4930918000.0,MEDANTA.NS
Total Unusual Items,2022-03-31 00:00:00,-33358000.0,MEDANTA.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-33358000.0,MEDANTA.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Reconciled Depreciation,2022-03-31 00:00:00,1297129000.0,MEDANTA.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,5429269000.0,MEDANTA.NS
EBITDA,2022-03-31 00:00:00,4897560000.0,MEDANTA.NS
EBIT,2022-03-31 00:00:00,3600431000.0,MEDANTA.NS
Net Interest Income,2022-03-31 00:00:00,-794860000.0,MEDANTA.NS
Interest Expense,2022-03-31 00:00:00,794860000.0,MEDANTA.NS
Interest Income,2022-03-31 00:00:00,167220000.0,MEDANTA.NS
Normalized Income,2022-03-31 00:00:00,1985306763.04075,MEDANTA.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Total Expenses,2022-03-31 00:00:00,18424379000.0,MEDANTA.NS
Rent Expense Supplemental,2022-03-31 00:00:00,537560000.0,MEDANTA.NS
Diluted Average Shares,2022-03-31 00:00:00,253650504.0,MEDANTA.NS
Basic Average Shares,2022-03-31 00:00:00,253236430.0,MEDANTA.NS
Diluted EPS,2022-03-31 00:00:00,7.73497,MEDANTA.NS
Basic EPS,2022-03-31 00:00:00,7.747618,MEDANTA.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,MEDANTA.NS
Net Income,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Minority Interests,2022-03-31 00:00:00,0.0,MEDANTA.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1961979000.0,MEDANTA.NS
Tax Provision,2022-03-31 00:00:00,843592000.0,MEDANTA.NS
Pretax Income,2022-03-31 00:00:00,2805571000.0,MEDANTA.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,385189000.0,MEDANTA.NS
Special Income Charges,2022-03-31 00:00:00,-33358000.0,MEDANTA.NS
Other Special Charges,2022-03-31 00:00:00,-26320000.0,MEDANTA.NS
Write Off,2022-03-31 00:00:00,33358000.0,MEDANTA.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-794860000.0,MEDANTA.NS
Total Other Finance Cost,2022-03-31 00:00:00,73680000.0,MEDANTA.NS
Interest Expense Non Operating,2022-03-31 00:00:00,794860000.0,MEDANTA.NS
Interest Income Non Operating,2022-03-31 00:00:00,167220000.0,MEDANTA.NS
Operating Income,2022-03-31 00:00:00,3248600000.0,MEDANTA.NS
Operating Expense,2022-03-31 00:00:00,12995110000.0,MEDANTA.NS
Other Operating Expenses,2022-03-31 00:00:00,3667398000.0,MEDANTA.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,1297129000.0,MEDANTA.NS
Amortization,2022-03-31 00:00:00,22560000.0,MEDANTA.NS
Depreciation Income Statement,2022-03-31 00:00:00,1297129000.0,MEDANTA.NS
Research And Development,2022-03-31 00:00:00,590000.0,MEDANTA.NS
Selling General And Administration,2022-03-31 00:00:00,2350972000.0,MEDANTA.NS
Selling And Marketing Expense,2022-03-31 00:00:00,31180000.0,MEDANTA.NS
General And Administrative Expense,2022-03-31 00:00:00,2350972000.0,MEDANTA.NS
Rent And Landing Fees,2022-03-31 00:00:00,537560000.0,MEDANTA.NS
Gross Profit,2022-03-31 00:00:00,16243710000.0,MEDANTA.NS
Cost Of Revenue,2022-03-31 00:00:00,5429269000.0,MEDANTA.NS
Total Revenue,2022-03-31 00:00:00,21672979000.0,MEDANTA.NS
Operating Revenue,2022-03-31 00:00:00,21672979000.0,MEDANTA.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,MEDANTA.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,MEDANTA.NS
Normalized EBITDA,2021-03-31 00:00:00,,MEDANTA.NS
Total Unusual Items,2021-03-31 00:00:00,,MEDANTA.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,MEDANTA.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,MEDANTA.NS
Reconciled Depreciation,2021-03-31 00:00:00,,MEDANTA.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,MEDANTA.NS
EBITDA,2021-03-31 00:00:00,,MEDANTA.NS
EBIT,2021-03-31 00:00:00,,MEDANTA.NS
Net Interest Income,2021-03-31 00:00:00,,MEDANTA.NS
Interest Expense,2021-03-31 00:00:00,,MEDANTA.NS
Interest Income,2021-03-31 00:00:00,177580000.0,MEDANTA.NS
Normalized Income,2021-03-31 00:00:00,,MEDANTA.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,MEDANTA.NS
Total Expenses,2021-03-31 00:00:00,,MEDANTA.NS
Rent Expense Supplemental,2021-03-31 00:00:00,364940000.0,MEDANTA.NS
Diluted Average Shares,2021-03-31 00:00:00,252056385.0,MEDANTA.NS
Basic Average Shares,2021-03-31 00:00:00,251408994.0,MEDANTA.NS
Diluted EPS,2021-03-31 00:00:00,1.14,MEDANTA.NS
Basic EPS,2021-03-31 00:00:00,1.15,MEDANTA.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,MEDANTA.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,MEDANTA.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,MEDANTA.NS
Net Income,2021-03-31 00:00:00,,MEDANTA.NS
Minority Interests,2021-03-31 00:00:00,,MEDANTA.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,MEDANTA.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,MEDANTA.NS
Tax Provision,2021-03-31 00:00:00,,MEDANTA.NS
Pretax Income,2021-03-31 00:00:00,,MEDANTA.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,MEDANTA.NS
Special Income Charges,2021-03-31 00:00:00,,MEDANTA.NS
Other Special Charges,2021-03-31 00:00:00,-29970000.0,MEDANTA.NS
Write Off,2021-03-31 00:00:00,142620000.0,MEDANTA.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,MEDANTA.NS
Total Other Finance Cost,2021-03-31 00:00:00,55400000.0,MEDANTA.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,MEDANTA.NS
Interest Income Non Operating,2021-03-31 00:00:00,177580000.0,MEDANTA.NS
Operating Income,2021-03-31 00:00:00,,MEDANTA.NS
Operating Expense,2021-03-31 00:00:00,,MEDANTA.NS
Other Operating Expenses,2021-03-31 00:00:00,,MEDANTA.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,MEDANTA.NS
Amortization,2021-03-31 00:00:00,20880000.0,MEDANTA.NS
Depreciation Income Statement,2021-03-31 00:00:00,,MEDANTA.NS
Research And Development,2021-03-31 00:00:00,270000.0,MEDANTA.NS
Selling General And Administration,2021-03-31 00:00:00,,MEDANTA.NS
Selling And Marketing Expense,2021-03-31 00:00:00,23880000.0,MEDANTA.NS
General And Administrative Expense,2021-03-31 00:00:00,,MEDANTA.NS
Rent And Landing Fees,2021-03-31 00:00:00,364940000.0,MEDANTA.NS
Gross Profit,2021-03-31 00:00:00,,MEDANTA.NS
Cost Of Revenue,2021-03-31 00:00:00,,MEDANTA.NS
Total Revenue,2021-03-31 00:00:00,,MEDANTA.NS
Operating Revenue,2021-03-31 00:00:00,,MEDANTA.NS
